Research Categories - Therapeutics
The range of studies that address therapeutics is expansive, encompassing biologic and cell-based therapies, small molecules, and diagnostics. Some examples include chimeric proteins for improving targeted therapy, stem cells for treating neurodegenerative diseases, radiolabeled prodrugs designed to offload cytotoxic activity only at the sites of tumors, and novel natural products having antibiotic properties.
Related Investigators
-
Jon Clardy, PhD
Isolation and characterization of small molecule natural products; high-throughput screening for novel therapeutics
Discovering small molecule, natural products and their biology; high throughput screening for small molecule chemicals that interfere with microbial and mammalian cell processes.

-
Michael Farzan, PhD
VIRAL ENTRY AND ANTI-VIRAL STRATEGIES Viral Receptors; HIV Therapy; Dengue Virus; SARS; Ebola Virus
Undertake translational studies geared toward the development of novel peptide mimetic inhibitors of HlV binding to its cell surface receptor, modeled after the CD4 and CCR5 HIV receptor/co-receptor; ...

-
Jose Halperin, MD
Targeting protein translation for anticancer therapies; CD59 and diabetes
Employ the preclinical resources of the Laboratory for Translational Research to develop new therapies and diagnostics in oncology and diabetes

-
Robert Paul Johnson, MD
HIV mechanism of action and new AIDS therapies
Gene therapy; vaccines

-
Amitinder Kaur, MD
AIDS pathogenesis and CMV opportunistic infection: SIV; vaccine; AIDS resistance
AIDS modeling in non-human primates; reactivation of latent CMV in HIV-infected individuals; innate resistance to SIV-related disease progression.

-
Roberto Kolter, PhD
Microbial physiology
Explore gene expression, community behavior, and biochemical aspects of bacterial biofilms; investigate microbial genomics.

-
Galit Lahav, PhD
The p53 tumor suppressor as a model for studying temporal dynamics of signaling networks
Investigate protein dynamics at the single cell level; quantification of proteins in live cells using fluorescence microscopy and mathematical modeling; cellular decision-making in cancer and healthy ...

-
David Sinclair, PhD
Sirtuins in aging and disease: calorie restriction; mitochondria; cancer; diabetes
Study sirtuin pathways, their role in multiple diseases and their lifespan extension capabilities.

-
Roger Spealman, PhD
CNS disorders: addiction; Parkinson’s disease
Studies on the mechanisms and efficacy of psychoactive drugs

-
Michael Starnbach, PhD
Bacterial infection and acquired immunity
T-cell response to bacterial infection, including sexually transmitted chlamydia disease

Sub-categories
-
Drug Development: Biologic Therapies
-
Drug Development: Cell-Based Therapies
-
Drug Development: Diagnostics
-
Drug Development: Non-Biologic Therapeutics and Small Molecules
- Adamantane»
- Anti-bacterial therapy»
- Anti-convulsant therapy»
- Anticancer therapy»
- Anticoagulant»
- Anticonvulsant therapy»
- Antifungal»
- Antioxidant»
- Antiviral small molecules»
- Antizyme»
- Anxiolytic»
- Benzodiazepine»
- Biologically-active small molecule»
- Cancer targets»
- Combination therapy»
- DNA damaging agents»
- Double mimetic»
- Druggable genome»
- EdU»
- HAART»
- Iressa»
- Medicinal chemistry»
- Muscle relaxant»
- Natural product»
- Natural products»
- Opioid»
- Peptide mimetic»
- Pharmacological agents»
- Prodrug»
- Recombinant toxins»
- Resveratol»
- Sedative»
- Small molecule chemistry»
- Small molecule inhibitors»
- Small molecule screens»
- Small molecule therapy»
- Small molecules»
- Soil microbe»
- Tarceva»